why choose us

First received: October 26, 2023

Clinical Trial: Safety and Tolerance Study of IBI355 in Health Volunteers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Subjects

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Double-blind Study to Evaluate the Safety and Tolerability of a Single-dose Administration of IBI355 in Health Adults

Brief Summary: This study is being done to find out if IBI355 is safe and tolerance in health volunteers.The study will test increasing single doses of IBI355 given to adult health volunteers.The goal is to confirmed the safety of the highest dose of IBI355 or to find out the highest dose of IBI35 that can be given to health volunteer that dose not cause unacceptable side effects.Different dose regimens will be evaluated.The pharmacokinetics and ADA of IBI355 will also be evaluated.

Read more